
Regeneron
North America, New York, United States, Tarrytown
Description
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
Investor Profile
Regeneron has backed more than 9 startups, with 1 new investments in the last 12 months alone. The firm has led 3 rounds, about 33% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Post Ipo Equity, Series C rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series B (22%)
- Post Ipo Equity (22%)
- Series C (22%)
- Series A (11%)
- Series G (11%)
- Corporate Round (11%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Biopharma
- Bioinformatics
- Cloud Computing
- Software
- Life Science
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.